The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.
Identifieur interne : 000C17 ( PubMed/Curation ); précédent : 000C16; suivant : 000C18The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.
Auteurs : Gavin C E. Stuart [Canada] ; Henry C. Kitchener ; Jan B. Vermorken ; Michael J. Quinn ; William Small ; Eric Pujade-Lauraine ; Hansen Chou ; Michelle Wong ; Monica BaconSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2017.
Abstract
The objective of this study was to demonstrate that the construction of the Gynecologic Cancer InterGroup (GCIG) has increased collaboration and accrual to high-quality phase 3 trials at a global level.
DOI: 10.1097/IGC.0000000000000934
PubMed: 28441253
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C20
Links to Exploration step
pubmed:28441253Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.</title><author><name sortKey="Stuart, Gavin C E" sort="Stuart, Gavin C E" uniqKey="Stuart G" first="Gavin C E" last="Stuart">Gavin C E. Stuart</name><affiliation wicri:level="1"><nlm:affiliation>*Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Kitchener, Henry C" sort="Kitchener, Henry C" uniqKey="Kitchener H" first="Henry C" last="Kitchener">Henry C. Kitchener</name></author><author><name sortKey="Vermorken, Jan B" sort="Vermorken, Jan B" uniqKey="Vermorken J" first="Jan B" last="Vermorken">Jan B. Vermorken</name></author><author><name sortKey="Quinn, Michael J" sort="Quinn, Michael J" uniqKey="Quinn M" first="Michael J" last="Quinn">Michael J. Quinn</name></author><author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name></author><author><name sortKey="Pujade Lauraine, Eric" sort="Pujade Lauraine, Eric" uniqKey="Pujade Lauraine E" first="Eric" last="Pujade-Lauraine">Eric Pujade-Lauraine</name></author><author><name sortKey="Chou, Hansen" sort="Chou, Hansen" uniqKey="Chou H" first="Hansen" last="Chou">Hansen Chou</name></author><author><name sortKey="Wong, Michelle" sort="Wong, Michelle" uniqKey="Wong M" first="Michelle" last="Wong">Michelle Wong</name></author><author><name sortKey="Bacon, Monica" sort="Bacon, Monica" uniqKey="Bacon M" first="Monica" last="Bacon">Monica Bacon</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28441253</idno><idno type="pmid">28441253</idno><idno type="doi">10.1097/IGC.0000000000000934</idno><idno type="wicri:Area/PubMed/Corpus">000C20</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C20</idno><idno type="wicri:Area/PubMed/Curation">000C17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C17</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.</title><author><name sortKey="Stuart, Gavin C E" sort="Stuart, Gavin C E" uniqKey="Stuart G" first="Gavin C E" last="Stuart">Gavin C E. Stuart</name><affiliation wicri:level="1"><nlm:affiliation>*Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Kitchener, Henry C" sort="Kitchener, Henry C" uniqKey="Kitchener H" first="Henry C" last="Kitchener">Henry C. Kitchener</name></author><author><name sortKey="Vermorken, Jan B" sort="Vermorken, Jan B" uniqKey="Vermorken J" first="Jan B" last="Vermorken">Jan B. Vermorken</name></author><author><name sortKey="Quinn, Michael J" sort="Quinn, Michael J" uniqKey="Quinn M" first="Michael J" last="Quinn">Michael J. Quinn</name></author><author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name></author><author><name sortKey="Pujade Lauraine, Eric" sort="Pujade Lauraine, Eric" uniqKey="Pujade Lauraine E" first="Eric" last="Pujade-Lauraine">Eric Pujade-Lauraine</name></author><author><name sortKey="Chou, Hansen" sort="Chou, Hansen" uniqKey="Chou H" first="Hansen" last="Chou">Hansen Chou</name></author><author><name sortKey="Wong, Michelle" sort="Wong, Michelle" uniqKey="Wong M" first="Michelle" last="Wong">Michelle Wong</name></author><author><name sortKey="Bacon, Monica" sort="Bacon, Monica" uniqKey="Bacon M" first="Monica" last="Bacon">Monica Bacon</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to demonstrate that the construction of the Gynecologic Cancer InterGroup (GCIG) has increased collaboration and accrual to high-quality phase 3 trials at a global level.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28441253</PMID><DateCreated><Year>2017</Year><Month>04</Month><Day>25</Day></DateCreated><DateRevised><Year>2017</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title><ISOAbbreviation>Int. J. Gynecol. Cancer</ISOAbbreviation></Journal><ArticleTitle>The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.</ArticleTitle><Pagination><MedlinePgn>813-818</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/IGC.0000000000000934</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to demonstrate that the construction of the Gynecologic Cancer InterGroup (GCIG) has increased collaboration and accrual to high-quality phase 3 trials at a global level.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The GCIG is a collaboration of 29 international cooperative clinical trial groups committed to conduct of high-quality phase 3 trials among women with gynecologic cancer. A complete bibliography of the reported phase 3 trials has been developed and is available on the GCIG Web site http://www.gciggroup.com. A "GCIG trial" is a trial in which any 2 or more GCIG member groups are formally involved. We reviewed the output of the GCIG from 1997 to 2015 with respect to member participation and quality of publication (impact factor and citation index). The publications are considered in 3 cohorts, 1997 to 2002, 2003 to 2008, and 2009 to 2014, for the purposes of comparison and progress. A social network map has been developed for these publications to identify how the GCIG has increased capacity for clinical trials globally.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using a global map, the number of member groups in the GCIG has increased in each of the 3 periods. The total annual number of publications and citations within the 1997 to 2015 period has increased significantly. The average number of citations per publication is demonstrated in each of the 3 periods. The steady increase in the number of citations is used as a proxy for the impact of the publications. The impact factor of the journal and the number of citations are reported for the 10 most highly cited publications. Finally, using a social networking methodology, networking has visibly and numerically increased in each of the 3 periods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Evidence supports that the construction of the GCIG has increased collaboration and accrual to high-quality phase 3 trials at a global level among women with gynecologic cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>Gavin C E</ForeName><Initials>GCE</Initials><AffiliationInfo><Affiliation>*Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; †Institute of Cancer Sciences, University of Manchester, Manchester, England; ‡European Organization for Research and Treatment for Cancer, Belgium; §Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Australia; ∥Department of Radiation Oncology, Loyola University Chicago, Chicago, IL; ¶AP-HP, Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France; #Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; and **Gynecologic Cancer InterGroup, Kingston, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitchener</LastName><ForeName>Henry C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Vermorken</LastName><ForeName>Jan B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>William</ForeName><Initials>W</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Pujade-Lauraine</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Hansen</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynecol Cancer</MedlineTA><NlmUniqueID>9111626</NlmUniqueID><ISSNLinking>1048-891X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28441253</ArticleId><ArticleId IdType="doi">10.1097/IGC.0000000000000934</ArticleId><ArticleId IdType="pii">00009577-201705000-00028</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000C17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:28441253
|texte= The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28441253" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |